EC tissues; adjacent normal tissue; tumor tissues
-
ceRNA regulation (other); other pathway/process (other); proliferation (other)
RNase R Treatment; Microarray; RT-qPCR; Clinical Sample Validation; Bioinformatics Analysis
May be a potential biomarker and therapeutic target for EC treatment.
hsa_circRNA_100375 is an up-regulated exonic circRNA in EC tumor tissues and was experimentally validated by RT-PCR. The study predicts that it participates in a cancer-related circRNA-miRNA axis with hsa-miR-324-3p, hsa-miR-29a-5p, hsa-miR-485-3p, and hsa-miR-149-5p, with downstream pathway-associated proteins including FGFR1, PTGER2, WNT9B, WNT2B, SP1, CREBBP, IL-6, and DVL2, suggesting potential biomarker and therapeutic target value.
0.5135
A microarray expression profile and bioinformatic analysis of circular RNA in human esophageal carcinoma.
combined biological and clinical study